Most Recent

image: Shire to Buy Baxalta for $32 Billion

Shire to Buy Baxalta for $32 Billion

By | January 12, 2016

The Dublin-based pharma giant is set to acquire Baxalta, an Illinois-based Baxter spinoff, expanding its rare disease drug portfolio.

0 Comments

image: Brain-Training Firm, FTC Settle

Brain-Training Firm, FTC Settle

By | January 6, 2016

San Francisco-based Lumos Labs, creator of the brain-training program Lumosity, will pay $2 million to settle deceptive-advertising charges raised by the US Federal Trade Commission.

0 Comments

image: Disease-Linked Genes Questioned

Disease-Linked Genes Questioned

By | January 6, 2016

Many patients with genetic variations linked to cardiac disorders do not exhibit any symptoms, raising concerns about the validity of incidental findings of genetic tests.

0 Comments

image: Updating the Polio Vaccine

Updating the Polio Vaccine

By | January 4, 2016

Researchers develop new attenuated viruses that could support the eradication effort.

1 Comment

image: Pluripotency Bots

Pluripotency Bots

By | January 1, 2016

A tour of efforts to automate the production and differentiation of induced pluripotent stem cells

0 Comments

image: Book Excerpt from <em>NeuroLogic</em>

Book Excerpt from NeuroLogic

By | January 1, 2016

In the introduction to the book, author Eliezer J. Sternberg illustrates what can happen when the brain’s processing centers are damaged.

0 Comments

image: Christie Fowler: Addicted to Research

Christie Fowler: Addicted to Research

By | January 1, 2016

Assistant Professor, Department of Neurobiology and Behavior University of California, Irvine. Age: 39

0 Comments

image: Flavor Savors

Flavor Savors

By | January 1, 2016

Odors experienced via the mouth are essential to our sense of taste.

2 Comments

image: Logically Illogical

Logically Illogical

By | January 1, 2016

The most bizarre behaviors often make perfect sense in the minds of the mentally ill.

3 Comments

image: Picking Up the Pace

Picking Up the Pace

By | January 1, 2016

FDA designations promise to expedite the approval of drugs for conditions ranging from infectious disease to cancer.

0 Comments

Popular Now

  1. Students Study Their Own Microbiomes
  2. Single Bacterial Species Improves Autism-Like Behavior in Mice
  3. Illustrating #FieldworkFails
  4. Transmissible Cancers Plague Mollusks
Biosearch Technologies